Hyderabad based drug firm Dr Reddy’s Laboratories has recently announced its launch of generic Zoledronic Acid injections in the US market. The injection in 4 mg/5 ml strength is approved by the US Food and Drug Administration (USFDA) and is available in single use vials.
The drug, which is a bioequivalent generic version of Novartis AG’s (NVS) Zometa, is used along with anti-cancer drugs to prevent bone fractures in patients with multiple myeloma and prostate cancer and for treating osteoporosis.
This has hiked the values of the firm’s share by nearly 1.06%.
Source-Medindia